Efficacy and Safety of Radiofrequency Ablation Performed by an Endocrinologist for Benign Thyroid Nodules

´ëÇÑ°©»ó¼±ÇÐȸÁö 2015³â 8±Ç 2È£ p.183 ~ p.186

:Kim Tae-Hyun :Kim Se-Mi/:Jung Ah-Lon/:Moon Seung-Ki/:Yang Dong-Hoon/:Park Cheol-Min/:Jo Shin-Hyoung/:Park Dae-Won/:Seo Seok-Ho/:Lee Seung-Hyun/:Kim Jong-Taek/:Kim Soon-Ho

Abstract

Background and Objectives: Radiofrequency ablation has recently been used for the treatment of benign thyroid nodules, with outstanding results. However, in most studies, the procedure was usually performed by a radiologist or surgeon. This study aimed to evaluate the efficacy and safety of radiofrequency ablation for nodules £¾2 cm performed by an endocrinologist with several years of experience performing fine-needle aspiration cytology.

Materials and Methods: This study was a cross-sectional analysis of 111 patients who received radiofrequency ablation between April 2010 and July 2013. A total of 73 patients with 75 nodules £¾2 cm in diameter with at least 6 months of follow-up examinations were included.

Results: The mean follow-up period was 11.5 months. The mean nodule volume decreased from 17.0¡¾15.3 mL preoperatively to 6.0¡¾8.5 mL postoperatively, with a mean volume reduction of 69.7%. There were no major complications, and only 1 patient (1.3%) presented with a minor complication (hemorrhaging of the thyroid parenchyma).

Conclusion: Radiofrequency ablation is a safe method for reducing benign thyroid nodules, and is not associated with any major complications.

Å°¿öµå

Radiofrequency ablation, Thyroid, Benign, Nodule, Endocrinologist
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
The mean nodule volume decreased from 17.0¡¾15.3 mL preoperatively to 6.0¡¾8.5 mL postoperatively, with a mean volume reduction of 69.7%. There were no major complications.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå